Premium
Disseminated herpes zoster infection 16 months after last intake of alemtuzumab: potential long‐term adverse effects
Author(s) -
Albrecht L. J.,
Moelleken M.,
Dissemond J.
Publication year - 2021
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14426
Subject(s) - alemtuzumab , medicine , adverse effect , dermatology , term (time) , immunology , antibody , physics , quantum mechanics